fewer patients treated with Somatuline Autogel/Somatuline Depot, reported interference with daily life as a result of injection-site pain (41% vs 60%). 1 Professor Dermot O’Toole, Consultant ...

(RTTNews) - Ipsen said that new patient-reported data demonstrated high satisfaction levels and fewer patients reporting injection-site pain with Somatuline Autogel/Somatuline Depot or lanreotide.

they’ll rotate the injection site between your right and left buttocks. In some cases, you may be able to have a nurse come to your home to give you your dose of Somatuline Depot. If you have qu ...

The most common adverse events with Somatuline Depot versus placebo were abdominal pain, musculoskeletal pain, vomiting, headache and injection site reaction. Severe adverse events occurred in 26 ...

A study assessing injection-site pain and device safety is expected ... the Ipsen Signes manufacturing site is around €60m. About Somatuline® Autogel® / Somatuline® Depot (lanreotide ...

The goal is to enable controlled, sustained injection and empower caregivers and patients to administer Somatuline Autogel ... being in a position to start a site pain and device safety trial ...

Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide ...

Patients with acromegaly require fortnightly or monthly injections of somatostatin analogs during clinic visits. The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS ...

fewer patients treated with Somatuline Autogel/Somatuline Depot, reported interference with daily life as a result of injection-site pain (41% vs 60%). 1 Professor Dermot O’Toole, Consultant ...

New data presented at ENETS 2022 showed patients treated with Somatuline Autogel /Somatline Depot (lanreotide) pre-filled syringe reported less frequent injection-site pain lasting more than two ...